Viveve Medical shares are trading lower after the company reported it will seek strategic alternatives and will be delisted from the Nasdaq. The company also announced its treatment for female stress urinary incontinence did not meet the primary endpoint.
$VIVE
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Health Care
Viveve Medical shares are trading lower after the company reported it will seek strategic alternatives and will be delisted from the Nasdaq. The company also announced its treatment for female stress urinary incontinence did not meet the primary endpoint.